Literature DB >> 681971

Chemical control of cerebral circulation. Modification by a new vasodilator (YC-93).

M Oishi, T Niimi, S Takagi, T Takeoka, T Seki, M Toyoda, F Gotoh.   

Abstract

This study was undertaken to investigate influences of a new vasodilator, YC-93, a derivative of 1,4-dihydropyridine, on cerebral circulation and cerebrovascular CO2 reactivity. Cerebrocortical PO2, cerebrocortical PCO2, cerebrocortical blood flow and arterial blood pressure were continuously recorded by means of a PO2 electrode, a PCO2 electrode and a plate-type crossed thermocouple flowmeter placed on an exposed pial surface of the cat brain. The changes in each parameter induced by YC-93 were compared with those induced by papaverine hydrochloride. The effects of 5% CO2 inhalation were compared before and after the intravenous injection of YC-93. YC-93 (0.01 mg/kg) showed a more marked and longer-lasting hypotensive effect that papaverine (1 mg/kg) and yet produced a significant increase in cerebrocortical PO2. After the administration of YC-93, the degree of the increase in cerebrocortical PO2 during 5% CO2 inhalation was reduced significantly in comparison with that before the administration. The above data indicates that YC-93 has a vasodilating effect on cerebral blood vessels and that the drug causes a decrease in cerebrovascular CO2 reactivity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 681971     DOI: 10.1016/0022-510x(78)90047-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Combined effects of hypocapnia and nicardipine on airway resistance: a pilot study.

Authors:  P Combes; B Fauvage
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

2.  Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.

Authors:  A Danielsson; P Bjerle; B Ek; L Steen; O Suhr
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Systemic vasomotor interaction between nicardipine and hypocapnic alkalosis in man.

Authors:  P Combes; B Fauvage
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 4.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

5.  Cardiovascular pharmacology of nicardipine in animals.

Authors:  T Takenaka; M Asano; K Shiono; M Shibasaki; O Inagaki
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Combined effects of nicardipine and hypocapnic alkalosis on cerebral vasomotor activity and intracranial pressure in man.

Authors:  P Combes; M Durand
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.